Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems

Sponsor
UConn Health (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05080777
Collaborator
Emory University (Other)
100
2
2
14.1
50
3.6

Study Details

Study Description

Brief Summary

This cluster randomized pragmatic clinical trial will test the effectiveness and feasibility of embedding the Tele-Savvy intervention, a psychoeducational program for family and other informal caregivers of older adults living in the community with Alzheimer's disease and related dementia (ADRD), in two health care systems/clinical sites: UConn Health in Farmington, Connecticut, and Emory Healthcare in Atlanta, Georgia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tele-Savvy
  • Behavioral: Caregiving During Crisis (Educational Program)
N/A

Detailed Description

This cluster randomized pragmatic clinical trial will test the effectiveness and feasibility of embedding the Tele-Savvy intervention, a psychoeducational program for family and other informal caregivers of older adults living in the community with Alzheimer's disease and related dementia (ADRD), in two health care systems/clinical sites: UConn Health in Farmington, Connecticut, and Emory Healthcare in Atlanta, Georgia. A total of 100 caregivers, 50 at each study site, will participate in this pilot study. At each site, 30 caregivers will be randomly assigned to receive the Tele-Savvy intervention, and 20 caregivers will be randomly assigned to receive the self-guided Caregiving During Crisis online program.

All 100 caregivers will complete identical self-administered questionnaires to measure the caregiver-specific outcome measures in this pilot study. Outcome measures will include caregiver mastery (primary outcome), caregiver response to specific memory and behavioral problems, and caregiver stress. Also, we will employ process measures of participation and engagement in the interventions for caregivers in both arms of the trial, as well as implementation outcomes via surveys with clinicians and Information Technology staff at each of the two clinical sites responsible for programming electronic medical records to enable capture and storage of caregiver outcomes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Three Tele-Savvy programs, with 10 caregivers in each Tele-Savvy program cohort, will be held sequentially at each health care system site, for a total of 60 caregivers in 6 Tele-Savvy cohorts. Recruitment will occur in three waves, whereby caregivers will be randomly assigned at a 3:2 ratio to either Tele-Savvy or the attention control group until the first Tele-Savvy cohort is filled (first wave), followed by the same randomization procedure until the second and third Tele-Savvy cohorts are filled.Three Tele-Savvy programs, with 10 caregivers in each Tele-Savvy program cohort, will be held sequentially at each health care system site, for a total of 60 caregivers in 6 Tele-Savvy cohorts. Recruitment will occur in three waves, whereby caregivers will be randomly assigned at a 3:2 ratio to either Tele-Savvy or the attention control group until the first Tele-Savvy cohort is filled (first wave), followed by the same randomization procedure until the second and third Tele-Savvy cohorts are filled.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
Actual Study Start Date :
Sep 28, 2021
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tele-Savvy Group

The participants will be enrolled into the Tele-Savvy group. Software analytics monitor caregivers' use of asynchronous material each week.

Behavioral: Tele-Savvy
A low-risk, psychoeducational, group-based intervention, is grounded in social learning and stress process theory and its main goal is to produce improved caregiver mastery over the symptom management skills commonly encountered when supervising and caring at home for an older adult living with ADRD. Over the 7-week program, there are synchronous and asynchronous activities each week. The synchronous portion includes weekly scheduled videoconferences (60-80 min) that serve as an online classroom in which facilitators lead lectures and discussions. Daily, caregivers access online 6- to 15-min prerecorded videos, each focused on one main learning objective. Caregivers can watch the lessons whenever and as often as they wish.

Active Comparator: Attention Control Group

The participants will be enrolled in the Caregiving During Crisis program. Software analytics monitor caregivers' use of asynchronous material each week.

Behavioral: Caregiving During Crisis (Educational Program)
The attention control group will receive the self-guided Caregiving During Crisis program. Caregiving During Crisis is a fully online, asynchronous, professionally designed continuing education course aimed at developing the competency of informal caregivers of community-dwelling persons living with dementia to ensure the safety of that person and themselves during this time of the COVID-19 pandemic. The course, readily accessible by home computer or smartphone, describes methods of home infection control and prevention to create a Safe Home space, strategies for safely leaving and re-entering the home (e.g., to shop), additional strategies for safely allowing service personnel (e.g., home health aides or electricians) and select family members to enter the Safe Home space, and risk management strategies to frame decisions when/if COVID restrictions are relaxed or revoked.

Outcome Measures

Primary Outcome Measures

  1. Change in Caregiver Mastery [pre-randomization; 3 months post-randomization; and 6 months post-randomization]

    Measured using a 4-item self-perceived caregiving competence scale.

Secondary Outcome Measures

  1. Change in Caregiver Reactions [pre-randomization; 3 months post-randomization for all; and 6 months post-randomization]

    The reactions caregivers have to the behavioral and psychological symptoms expressed by persons living with dementia, using the Revised Memory and Behavior Problem Checklist (RMBPC). The RMBPC is a 24-item scale capturing caregiver reactions to 24 memory and behavior problems. Scores are computed based on the presence or absence of each problem first, and then for caregiver "reaction" or the extent to which caregivers were "bothered" or "upset" by each behavior.

  2. Change in Caregiver Stress [pre-randomization; 3 months post-randomization for all; and 6 months post-randomization]

    The Perceived Stress Scale (PSS) will be used to quantify caregiver stress levels. The PSS is a 14-item measure. Higher score reflects higher perceived stress

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Identified by EHR systems and confirmed by a health care provider as a family member or unpaid significant other who provides care at home for an older adult (age 65 or older) living with ADRD

  • English speaking

  • Able to understand study procedures and comply with them for the entire length of the study

  • Access to appropriate video and audio technology to be able to participate in interventions

Exclusion Criteria:
  • Unwilling to be randomized to receive either Tele-Savvy or Caregiving During Crisis

  • Planning to admit the person living with ADRD to a nursing home on a long-term basis within 6 months of randomization.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UConn Health (Geriatrics Associates) Farmington Connecticut United States 06032
2 Emory HealthCare (IMCC) Atlanta Georgia United States 30329

Sponsors and Collaborators

  • UConn Health
  • Emory University

Investigators

  • Principal Investigator: Richard H. Fortinsky, PhD, UConn Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fortinsky, Richard, Professor, UConn Health
ClinicalTrials.gov Identifier:
NCT05080777
Other Study ID Numbers:
  • U21-139-2
First Posted:
Oct 18, 2021
Last Update Posted:
Mar 2, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022